financetom
Business
financetom
/
Business
/
Wilmington Capital Management Seeks Approval for a Return of Capital to Shareholders
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wilmington Capital Management Seeks Approval for a Return of Capital to Shareholders
Apr 2, 2024 5:58 AM

08:39 AM EDT, 04/02/2024 (MT Newswires) -- Wilmington Capital Management (WCM-A.TO, WCM-B.TO) late Monday said it will seek to reduce stated capital and return capital involving Class A and B shares as partial payment for a special dividend it declared last month.

Wilmington in a statement said the Class A and B reductions together will result in an aggregate reduction in stated capital of near $15.28 million

If approved, the Class A Reduction will be distributed to Class A shareholders as a return of capital in an amount equal to $1.25 per Class A share, and the Class B Reduction will be distributed to Class B shareholders as a return of capital in an amount equal to $1.12 per Class B share.

"The corporation has determined that it is necessary and desirable to effect the return of capital as partial payment for the corporation's previously announced special dividend of $2.75 per share. The portion of the special dividend not paid by way of the return of capital will be paid in cash in an amount of $1.50 and $1.63 per Class A share and Class B share, respectively. Regardless of whether the reduction in stated capital is approved, shareholders will receive $2.75 per share. However, approval of the Reduction in Stated Capital and the corresponding payment of the Class A Return and the Class B Return as a return of capital is expected to be preferred by shareholders," the company said.

The company's Class A shares last traded March 28, closing at C$3.00 on the Toronto Stock Exchange, while the Class B shares last traded March 4, closing at C$7.55.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing
Jun 5, 2024
05:05 PM EDT, 06/05/2024 (MT Newswires) -- Marc N Casper, Director, Chairman & CEO, on June 03, 2024, sold 20,000 shares in Thermo Fisher Scientific ( TMO ) for $11,374,358. Following the Form 4 filing with the SEC, Casper has control over a total of 183,724 shares of the company, with 123,816 shares held directly and 59,908 controlled indirectly. SEC...
Ventyx Biosciences Preclinical Study of Obesity Control Candidate Shows Positive Results
Ventyx Biosciences Preclinical Study of Obesity Control Candidate Shows Positive Results
Jun 5, 2024
05:04 PM EDT, 06/05/2024 (MT Newswires) -- Ventyx Biosciences ( VTYX ) said Wednesday that VTX3232 effectively reduced body weight and food intake during two preclinical diet-induced obesity mouse model studies. The results show that the drug decreased liver steatosis and triglycerides, and also had greater benefits in combination with semaglutide, according to the company. The company said it plans...
Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment
Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment
Jun 5, 2024
05:04 PM EDT, 06/05/2024 (MT Newswires) -- Relay Therapeutics ( RLAY ) unveiled late Wednesday a clinical trial collaboration with Pfizer ( PFE ) to evaluate a treatment for patients with PI3Ka-mutated, HR+, HER2- metastatic breast cancer. The partnership is evaluating atirmociclib, Pfizer's ( PFE ) investigative selective-CDK4 inhibitor, in combination with RLY-2608 and fulvestrant, Relay Therapeutics ( RLAY )...
Kyndryl Holdings Insider Sold Shares Worth $802,244, According to a Recent SEC Filing
Kyndryl Holdings Insider Sold Shares Worth $802,244, According to a Recent SEC Filing
Jun 5, 2024
05:04 PM EDT, 06/05/2024 (MT Newswires) -- Vineet Khurana, Senior Vice President & Global Controller, on June 03, 2024, sold 30,430 shares in Kyndryl Holdings ( KD ) for $802,244. Following the Form 4 filing with the SEC, Khurana has control over a total of 78,722 shares of the company, with 78,722 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1867072/000112760224017950/xslF345X03/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved